Diogo Rau

And with some of the medicines that are out there right now, there's a huge financial incentive for people to say that they're making medicines that they really are not, and they're faking them.

And with some of the medicines that are out there right now, there's a huge financial incentive for people to say that they're making medicines that they really are not, and they're faking them.

Well, right now, in chronic weight management, we have the GLP-1 medicines. And so, both for us and the other leading maker of GLP-1 medicines... Counterfeiting is a real, real threat. And back to formularies and things like that, a lot of insurance plans do not cover chronic weight loss management.

Well, right now, in chronic weight management, we have the GLP-1 medicines. And so, both for us and the other leading maker of GLP-1 medicines... Counterfeiting is a real, real threat. And back to formularies and things like that, a lot of insurance plans do not cover chronic weight loss management.

And so there's a huge financial incentive on the black market to say, hey, we're going to go... And some uncertainty about outcomes. So it would take you a while to figure out you're taking a fake. Correct. And I mean, it's not only...

And so there's a huge financial incentive on the black market to say, hey, we're going to go... And some uncertainty about outcomes. So it would take you a while to figure out you're taking a fake. Correct. And I mean, it's not only...

I mean, it's not only fake, it's actually, many of these cases are risky because once you see, once you see like the sterile environments that these medicines go through to be made, you know, that it could, in the best case, it's harmless, right? I mean, the best case is you don't get any effect. And so what I've got here is a product. I'm going to, this can be any product.

I mean, it's not only fake, it's actually, many of these cases are risky because once you see, once you see like the sterile environments that these medicines go through to be made, you know, that it could, in the best case, it's harmless, right? I mean, the best case is you don't get any effect. And so what I've got here is a product. I'm going to, this can be any product.

And so don't pay attention to what product this actually is. And I've got the product right here and I can tap my phone against it and I will get it in an NFC tag. And that NFC tag is just like when you do a contactless payment. And it will bring up a page to show you that could actually verify that the packaging matches something that we've produced. Unlike a QR code, it can't be copied.

And so don't pay attention to what product this actually is. And I've got the product right here and I can tap my phone against it and I will get it in an NFC tag. And that NFC tag is just like when you do a contactless payment. And it will bring up a page to show you that could actually verify that the packaging matches something that we've produced. Unlike a QR code, it can't be copied.

It's cryptographically secure. And this is where the technology part gets interesting because they can copy the box. They can do all kinds of things like that, but they can't copy that tag. There's one and only one tag that you can tap and then we can verify it.

It's cryptographically secure. And this is where the technology part gets interesting because they can copy the box. They can do all kinds of things like that, but they can't copy that tag. There's one and only one tag that you can tap and then we can verify it.

So this is something we did within my first few months of coming here. And we haven't launched it yet. So the designing it is very easy. The developing it is very hard.

So this is something we did within my first few months of coming here. And we haven't launched it yet. So the designing it is very easy. The developing it is very hard.

Correct. And the manufacturer. That's absolutely right. And, you know, we actually don't even care about it necessarily being just for us. Like, this is the kind of thing where we'd say, this is a great thing if adherence can improve for patients across all medicines, all manufacturers, that would be fantastic.

Correct. And the manufacturer. That's absolutely right. And, you know, we actually don't even care about it necessarily being just for us. Like, this is the kind of thing where we'd say, this is a great thing if adherence can improve for patients across all medicines, all manufacturers, that would be fantastic.

So this is version one, which is on the box. And then version two, which we'll come to later, will be on the individual medicine itself.

So this is version one, which is on the box. And then version two, which we'll come to later, will be on the individual medicine itself.

Absolutely. Then you could actually make sure that you're taking the right medicine. I also think making sure that you haven't taken your medicine more than once in a day is also an important thing because you know what? It's actually very easy to do.

Absolutely. Then you could actually make sure that you're taking the right medicine. I also think making sure that you haven't taken your medicine more than once in a day is also an important thing because you know what? It's actually very easy to do.